Genetic control of cultivated human stem cells;Controle genético das células-tronco humanas cultivadas

Revista Brasileira de Hematologia e Hemoterapia

Volumn 31, Issue SUPPL. 1, 2009, Pages 15-18

  Payão, Spencer L M ^a   Segato, Rosimeire ^b   Santos, Ricardo R ^c  

^a FACULDADE DE MEDICINA DE MARÍLIA   (Brazil)

^b Hemocentro Famema   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Cultivated stem cells; Cytogenetic control; G banding; SKY (spectral karyotyping)

Indexed keywords

EID: 69849112710     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-84842009005000021     Document Type: Review

References (20)

1. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer. 2003;3(12):895-902.
2. Czyz J, Wiese C, Rolletschek A, Blyszczuk P, Cross M, Wobus AM. Potential of embryonic and adult stem cells in vitro. Biol Chem. 2003;384(10-11):1391-409.
3. van Steensel B, Smogorzewska A, de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell. 1998;92(3):401-13.
4. Masutomi K, Hahn WC. Telomerase expression - only half the story. Cancer Biol Ther. 2003;2(6):685-6.
5. Sharpless NE, DePinho RA. Telomeres, stem cells, senescence, and cancer. J Clin Invest. 2004;113(2):160-8.
6. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100(9):1249-60.
7. Lloyd AC. Limits to lifespan. Nat Cell Biol. 2002;4(2):E25-7.
8. Rubio D, Garcia-Castro J, Martín MC, de la Fuente R, Cigudosa JC, Lloyd AC, et al. Spontaneous human adult stem cell transformation. Cancer Res. 2005;65(8):3035-9.
9. Catalina P, Cobo F, Cortés JL, Nieto AI, Cabrera C, Montes R, et al. Conventional and molecular cytogenetic diagnostic methods in stem cell research: A concise review. Cell Biol Int. 2007; 31(9):861-9.
10. Duesberg P, Li R, Fabarius A, Hehlmann R. The chromosomal basis of cancer. Cell Oncol. 2005;27(5-6):293-318.
11. Hoffman LM, Carpenter MK. Human embryonic stem cell stability. Stem Cell Rev. 2005;1(2):139-44.
12. Meisner LF, Johnson JA. Protocols for cytogenetic studies of human embryonic stem cells. Methods. 2008;45(2):133-41.
13. Storchova Z, Pellman D. From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol. 2004;5(1):45-54.
14. Comai L. The advantages and disadvantages of being polyploid. Nat Rev Genet. 2005;6(11):836-46.
15. Ganem NJ, Storchova Z, Pellman D. Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev. 2007;17(2):157-62.
16. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer. 1994;10(4):231-43.
17. Bayani J, Squire JA. Advances in the detection of chromosomal aberrations using spectral karyotyping. Clin Genet. 2001;59(2):65-73.
18. Fan YS, Siu VM, Jung JH, Xu J. Sensitivity of multiple color spectral karyotyping in detecting small interchromosomal rearrangements. Genet. Genet Test. 2000;4(1):9-14.
19. Sanchez O, Escobar JI, Yunis JJ. A simple G-banding technique. Lancet. 1973;2(7823):269.
20. ISCN: An International System for Human Cytogenetic Nomenclature. Mitelman F. ed. Karger, Basel, 2005, P 130.